Sarepta Therapeutics Inc (SRPT) Ownership

110.86 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Sarepta Therapeutics Inc (SRPT), owning a total of 10.3 million shares. Combined, the top 39 institutional holders of SRPT own 85.56% of the company with a total of 81.1 million shares.

In the latest ownership report on June 30th 2024, the top 39 institutional holders increased their combined ownership of SRPT by 5.8 million shares. 12 institutions bought 11,047,765 total additional shares and increased their ownership by an average of 36.41%. However 8 institutions sold 5,204,558 total shares and decreased their ownership by an average of 21.12%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Sarepta Therapeutics increased by a net total of 5,843,207 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.812%73.218%10,324,4044,364,0342024-06-30
Vanguard Group Inc9.462%2.727%9,035,624239,8702024-06-30
Morgan Stanley - Brokerage Accounts5.494%195.280%5,246,7223,469,8562024-06-30
Capital Research & Mgmt Co - Division 34.525%-10.310%4,320,827-496,6902024-06-30
State Street Corp4.337%95.138%4,141,7932,019,3022024-06-30
HHG PLC3.995%-21.999%3,815,368-1,076,0492024-06-30
venBio Select Advisor LLC3.142%-30.946%3,000,000-1,344,4442024-06-30
Farallon Capital Management, L.L.C.2.403%-6.460%2,295,000-158,5002024-06-30
Bank of New York Mellon Corp2.231%3.078%2,130,65163,6142024-06-30
Wellington Management Company LLP2.159%-36.486%2,061,526-1,184,2722024-06-30
T. Rowe Price Investment Management,Inc.2.051%1.402%1,958,63527,0882024-06-30
FMR Inc1.948%37.964%1,860,545511,9752024-06-30
JPMorgan Chase & Co1.931%0.829%1,843,76915,1672024-06-30
Geode Capital Management, LLC1.730%8.661%1,652,048131,6782024-06-30
Deutsche Bank AG1.648%7.744%1,573,577113,1022024-06-30
EcoR1 Capital, LLC1.474%-26.696%1,407,322-512,5132024-06-30
Casdin Capital, LLC1.124%0.421%1,073,5004,5002024-06-30
Pictet Asset Manangement SA1.002%-23.942%957,218-301,3182024-06-30
Paradigm Biocapital Advisors LP0.992%-12.127%947,574-130,7722024-06-30
NORGES BANK0.968%10.465%924,42887,5792024-06-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.812%73.218%10,324,4044,364,0342024-06-30
Vanguard Group Inc9.462%2.727%9,035,624239,8702024-06-30
Morgan Stanley - Brokerage Accounts5.494%195.280%5,246,7223,469,8562024-06-30
Capital Research & Mgmt Co - Division 34.525%-10.310%4,320,827-496,6902024-06-30
State Street Corp4.337%95.138%4,141,7932,019,3022024-06-30
HHG PLC3.995%-21.999%3,815,368-1,076,0492024-06-30
venBio Select Advisor LLC3.142%-30.946%3,000,000-1,344,4442024-06-30
Farallon Capital Management, L.L.C.2.403%-6.460%2,295,000-158,5002024-06-30
Bank of New York Mellon Corp2.231%3.078%2,130,65163,6142024-06-30
State Street Corporation2.226%-11.529%2,122,491-276,5872024-03-31
Wellington Management Company LLP2.159%-36.486%2,061,526-1,184,2722024-06-30
T. Rowe Price Investment Management,Inc.2.051%1.402%1,958,63527,0882024-06-30
FMR Inc1.948%37.964%1,860,545511,9752024-06-30
JPMorgan Chase & Co1.931%0.829%1,843,76915,1672024-06-30
Geode Capital Management, LLC1.730%8.661%1,652,048131,6782024-06-30
Deutsche Bank AG1.648%7.744%1,573,577113,1022024-06-30
EcoR1 Capital, LLC1.474%-26.696%1,407,322-512,5132024-06-30
Camber Capital Management LLC1.342%-16.667%1,250,000-250,0002022-12-31
Alkeon Capital Management, LLC1.403%6.486%1,231,39675,0002022-09-30
Citadel Advisors Llc1.308%37.864%1,227,974337,2612023-09-30
Bank of America Corp1.283%129.684%1,212,377684,5312023-12-31
T. Rowe Price Associates, Inc.1.256%40.009%1,171,442334,7492023-03-31
Assenagon Asset Management SA1.286%154.758%1,129,016685,8452022-09-30
Casdin Capital, LLC1.124%0.421%1,073,5004,5002024-06-30
Lord, Abbett & Co LLC1.138%-0.436%1,059,572-4,6422022-12-31
Avidity Partners Management LP1.133%11.263%1,055,000106,8002022-12-31
Two Sigma Advisers, LLC1.091%-18.937%1,020,934-238,5002023-09-30
Goldman Sachs Group Inc1.036%27.862%969,288211,2162023-06-30
Federated Hermes Inc1.030%-0.197%963,049-1,8982023-09-30
Pictet Asset Manangement SA1.002%-23.942%957,218-301,3182024-06-30
American Century Companies Inc1.022%39.630%953,204270,5422023-03-31
Paradigm Biocapital Advisors LP0.992%-12.127%947,574-130,7722024-06-30
NORGES BANK0.968%10.465%924,42887,5792024-06-30
First Trust Advisors L.P.1.043%32.877%917,242226,9472022-09-30
Sands Capital Management, LLC0.938%-59.339%874,765-1,276,6132023-03-31
Millennium Management LLC0.917%35.708%874,147230,0092024-03-31
Orbimed Advisors, LLC0.927%-11.025%865,100-107,2002023-03-31
Thrivent Financial For Lutherans0.886%31.341%828,708197,7472023-12-31
Two Sigma Investments LLC0.866%-37.134%810,467-478,7312023-09-30

Mutual Fund Ownership

iShares Core S&P Mid-Cap ETF is the biggest individual fund holder of Sarepta Therapeutics Inc (SRPT), owning a total of 3 million shares. Combined, the top 42 mutual fund holders of SRPT own 52.03% of the company with a total of 49.1 million shares.

In the latest ownership report on October 31st 2024, the top 42 fund holders increased their combined ownership of SRPT by 19 thousand shares. 1 funds bought 1,632 total additional shares and increased their ownership by an average of 0.05%. However 1 funds sold 21,084 total shares and decreased their ownership by an average of 1.42%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Sarepta Therapeutics decreased by a net total of -19,452 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Core S&P Mid-Cap ETF3.144%0.054%3,002,6841,6322024-10-31
SPDR® S&P Biotech ETF1.529%-1.423%1,460,503-21,0842024-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Core S&P Mid-Cap ETF3.144%0.054%3,002,6841,6322024-10-31
Vanguard Total Stock Mkt Idx Inv2.989%0.076%2,854,3392,1562024-09-30
Vanguard Instl Ttl Stck Mkt Idx Tr2.759%1.677%2,580,74142,5632023-03-31
Vanguard Small Cap Index2.375%-0.159%2,267,946-3,6112024-09-30
Capital Group AMCAP Composite2.198%75.444%2,099,199902,6922024-09-30
VA CollegeAmerica Amcap 529A2.198%75.444%2,099,199902,6922024-09-30
Vanguard Health Care Inv1.733%30.929%1,655,006390,9602024-09-30
Capital Group Growth Fnd of Amer Comp1.732%13.342%1,654,174194,7262024-09-30
American Funds Growth Fund of Amer A1.732%13.342%1,654,174194,7262024-09-30
SPDR® S&P Biotech ETF1.529%-1.423%1,460,503-21,0842024-10-31
JPMorgan Large Cap Growth I1.560%0.000%1,458,93702023-09-30
JPM US Large Cap Growth-MA1.560%810.692%1,458,9371,298,7362023-09-30
Vanguard Institutional Extnd Mkt Idx Tr1.493%-1.307%1,425,991-18,8772024-09-30
Vanguard Extended Market Index Investor1.395%0.369%1,300,9964,7762023-08-31
Sands Select Growth Equity1.455%1,698.360%1,277,1041,206,0892022-12-31
Vanguard Small Cap Growth Index Inv1.310%-0.469%1,250,592-5,8912024-09-30
Capital Group Fundamental Invtrs Comp1.122%13.530%1,071,372127,6812024-09-30
American Funds Fundamental Invs A1.122%13.530%1,071,372127,6812024-09-30
Janus Inst Mid Cap Growth CF0.989%4.583%944,69541,4002024-09-30
Janus Henderson Enterprise D0.989%9.461%944,69581,6532024-08-31
T. Rowe Price US Mid-Cap Growth Equity0.934%-0.280%891,900-2,5002024-09-30
T. Rowe Price Mid-Cap Growth0.934%-0.213%891,900-1,9002024-09-30
DWS Vermögensbildungsfonds I LD0.884%0.000%843,80102024-09-30
American Century Heritage Inv0.892%42.068%830,951246,0552023-03-31
American Century US Opport. Mid Cap Gr0.892%42.068%830,951246,0552023-03-31
Janus Global Life Science A USD0.895%-8.708%787,032-75,0672022-12-31
Janus Henderson Gbl Life Sciences Divers0.816%1,186,510.000%771,297771,2322024-03-31
SPDR® S&P MIDCAP 400 ETF Trust0.797%0.921%761,1296,9492024-09-30
Janus Henderson Global Life Sciences D0.728%4.359%694,91729,0282024-08-31
Janus Henderson Glb Life Scn I2 USD0.742%-1.380%694,377-9,7182023-12-31
Bellevue Healthcare Ord0.744%-39.002%693,133-443,1922022-11-30
Janus Henderson US Research Growth Eq0.726%1.489%679,1489,9622023-09-30
Janus Henderson Research D0.726%1.489%679,1489,9622023-09-30
Fidelity® Select Health Care0.763%-4.286%670,000-30,0002022-12-31
T. Rowe Price Health Sciences0.719%46.647%669,913213,0932023-03-31
BNY Mellon Sm/Md Cp Gr I0.711%-1.247%664,946-8,3992023-09-30
Janus Henderson Global Life Sciences0.689%-14.773%657,353-113,9442024-06-30
iShares Biotechnology ETF0.669%-0.376%632,070-2,3882024-05-30
Janus Selection Global Life Science AUSD0.620%-15.546%586,429-107,9482024-03-31
Hartford MidCap Y0.611%7.202%569,62438,2662023-08-31
Janus Henderson Triton D0.579%-7.176%539,588-41,7162023-06-30
Janus Henderson US SMID Cap Growth0.579%-7.176%539,588-41,7162023-06-30

Discussions

Please log in or register to share your thoughts.

4texin

$SRPT just added more

0 Like Report
dogefan77

$SRPT I’m selling y’all have fun bag holding

0 Like Report